Cargando…

4. A challenging case of refractory BehÇet's disease in an adolescent with sight threatening uveitis

Detalles Bibliográficos
Autores principales:	Cooper, Gisella, Choi, Jessica, McMahon, Anne-Marie, Nash, Clare, Dunkley, Lisa, Tattersall, Rachel, Quhill, Fahd, Lee, Helen, Edgerton, Jenny, Welch, F, Verstegen, Ruud, Hawley, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	A. CASE REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652640/ http://dx.doi.org/10.1093/rap/rky031.003

Ejemplares similares

40. Rivaroxaban for treatment of vascular BehÇet's disease
por: Musa, Reem, et al.
Publicado: (2018)

88. Fibromyalgia in BehÇet's disease: any role for helicobacter screen and eradication?
por: Bashir, Yasmin, et al.
Publicado: (2018)

3. Certolizumab pegol for BehÇet's flare in pregnancy: a case report
por: Piper, Madeleine, et al.
Publicado: (2017)

O16 A diagnosis of BehÇet’s Disease with secondary antiphospholipid syndrome
por: Jones, Alexandra, et al.
Publicado: (2021)

20. Neurovascular BehÇet’s syndrome: lessons in management from a centre of excellence
por: Dolan, Lauren A, et al.
Publicado: (2018)

87. Cardiac presentation of BehÇet's disease: the impact of HLA-B51 positivity in early diagnosis
por: Adamjee, Qainat R, et al.
Publicado: (2018)

50. Vascular BehÇet’s disease in a 20-year-old man presenting with an abdominal aortic aneurysm
por: Levasseur, Kirsty, et al.
Publicado: (2019)

5. Paediatric Takayasu arteritis
por: Mackay, Madeleine, et al.
Publicado: (2018)

Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet’s disease-related uveitis
por: Ho, Mary, et al.
Publicado: (2019)

P42 Primary Sjogren’s Syndrome (pSS) in a seronegative adolescent female with family history of BehÇet’s disease: A challenging disease to diagnose Case-based discussion
por: Gharaibeh, Aseel, et al.
Publicado: (2022)

Low-dose cyclosporine treatment for sight-threatening uveitis: Efficacy, toxicity, and tolerance
por: Mathews, D, et al.
Publicado: (2010)

Behçet's Uveitis
por: Tugal-Tutkun, Ilknur
Publicado: (2009)

Behçet’s Disease Uveitis
por: Joubert, Morgane, et al.
Publicado: (2023)

BEH fermionic decays
por: Dell'Asta, Lidia
Publicado: (2016)

O18 The Rollercoaster Reality of Mixed Connective Tissue disease
por: Elfadil, Maysoon, et al.
Publicado: (2020)

Cet été qui chantait /
por: Roy, Gabrielle, 1909-1983
Publicado: (1979)

Macular involvement in patients with Behçet’s uveitis
por: Kahloun, Rim, et al.
Publicado: (2012)

Vitreomacular Interface Disorders in Behçet’s Uveitis
por: Eser Öztürk, Hilal, et al.
Publicado: (2017)

Successful treatment of Behçet’s uveitis with Tocilizumab
por: Alokaily, F., et al.
Publicado: (2017)

Characterization of CetA and CetB, a bipartite energy taxis system in Campylobacter jejuni
por: Elliott, Kathryn T, et al.
Publicado: (2008)

Signal Balancing by the CetABC and CetZ Chemoreceptors Controls Energy Taxis in Campylobacter jejuni
por: Reuter, Mark, et al.
Publicado: (2013)

The BEH mechanism and its scalar bosons
por: Englert, Francois
Publicado: (2014)

Real-Life ILUVIEN (Fluocinolone Acetonide) Case Study: Rapid Drying of the Macula and Improved Vision within 2 Years after Therapy Initiation
por: Quhill, Hibba, et al.
Publicado: (2016)

Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT
por: Gilbert, Rose M., et al.
Publicado: (2018)

An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma
por: Ghanchi, Faruque, et al.
Publicado: (2022)

Gender Differences in Behçet's Disease Associated Uveitis
por: Ucar-Comlekoglu, Didar, et al.
Publicado: (2014)

Behçet’s Uveitis: Current Diagnostic and Therapeutic Approach
por: Çakar Özdal, Pınar
Publicado: (2020)

Behçet uveitis: Current practice and future perspectives
por: Aboul Naga, Shereen H., et al.
Publicado: (2022)

How challenging can it be to treat Behçet uveitis?
por: Oray, Merih, et al.
Publicado: (2022)

Commentary: Behçet’s uveitis – Expanding treatment horizons
por: Moreker, Mayur R
Publicado: (2023)

Understanding and managing sight-threatening diabetic retinopathy
por: Yorston, David
Publicado: (2023)

Comparison of Sociodemographic Features Between Behçet Uveitis and Other Non-infectious Uveitis
por: Yalçındağ, F. Nilüfer, et al.
Publicado: (2021)

BEH Boson properties from CMS results
por: Checchia, Paolo
Publicado: (2016)

Case Series Investigating the Efficacy and Safety of Bilateral Fluocinolone Acetonide (ILUVIEN(®)) in Patients with Diabetic Macular Edema: 10 Eyes with 12 Months Follow-up
por: Elaraoud, Ibrahim, et al.
Publicado: (2016)

Associations between vitamin D status and sight threatening and non-sight threatening diabetic retinopathy: a systematic review and meta-analysis
por: Trott, Mike, et al.
Publicado: (2022)

Test sur faisceau cet ete (memo)
por: Callot, O
Publicado: (1986)

Consequential research of accountability testing: the case of the CET
por: Jin, Yan
Publicado: (2022)

P03-009 - Experiences of in pediatric Behçet uveitis
por: Sozeri, B, et al.
Publicado: (2013)

Pattern of Uveitis Associated with Behçet’s Disease in an Egyptian Cohort
por: Abd El Latif, Eiman, et al.
Publicado: (2020)

Old and New Challenges in Uveitis Associated with Behçet’s Disease
por: Gueudry, Julie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i19tlqd4274dj2mh04hav1ien7